Remove finance
article thumbnail

TORL rakes in $158m for ADCs, and other bio financings

pharmaphorum

Our regular round-up of financings in the biotech sector features rounds for TORL BioTherapeutics, Nvelop Therapeutics, D3 Bio, and Century Therapeutics.

110
110
article thumbnail

Mirador’s massive $400m first round, and other financings

pharmaphorum

It has been a bumper week for biotech financings, with a $400m Series A for Mirador heading, topping impressive rounds for Capstan, Clasp, Engrail, Enliven, and Nouscom.

103
103
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Aardvark said to be planning IPO, plus other bio financings

pharmaphorum

Our regular round-up of financings in the biotech sector is headed by rumours of a $150 to $200 million initial public offering (IPO) for Aardvark Therapeutics, an emerging player in the weight-loss category, alongside a trio of big private rounds.

105
105
article thumbnail

Freenome raises $254m for cancer tests, and other financings

pharmaphorum

Recent biotech financings include a $245m raise for cancer blood test company Freenome, plus big rounds for Cogent Biosciences, BioAge Labs, Latigo Biotherapeutics, ProfoundBio, and Firefly Bio

118
118
article thumbnail

STAT+: An inside look at PIPEs, the financing trend that has biotech abuzz

STAT

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million. Continue to STAT+ to read the full story…

140
140
article thumbnail

Senate Finance Committee Urges PBMs To Make Big Changes

Drug Topics

Members of the Senate Finance Committee are pushing PBMs to modernize the rules regarding out of pocket costs and competition.

187
187
article thumbnail

Synnovation’s $102m round heads latest biotech financings

pharmaphorum

Our latest crop of biotech financings features rounds for Synnovation Therapeutics and Adicet Bio, Calluna Pharma, Accent Therapeutics, GenEdit and IMU Bio

106
106